At present, approximately 25%of drugs in modern pharmacopoeia are derived from plant sources (phytomedicines)
that can be developed for the treatment of diseases and disorders. Many other drugs are synthetic analogues built on
the prototype compounds isolated from plants. Cocos nucifera Linn. (Arecaceae), which is commonly known as coconut,
is a plant possessing a lot of potential as an ingredient in traditional medicines for the treatment of metabolic disorders and
particularly as an anti-inflammatory, antimicrobial and analgesic agent. This review emphasizes on the recent literature
and research findings that highlight the significant biological activities of C. nucifera Linn. such as its anti-inflammatory,
antimicrobial and analgesic properties. This review can help researchers keen on exploiting the therapeutic potential of C.
nucifera Linn. which may motivate them to further explore their commercial viability.